A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone

INTRODUCTION: Pioglitazone has been a cornerstone of oral hypoglycemic therapy. Concerns have been raised about its association with urinary bladder cancer. Considering the wide usage of this drug, concrete and multiple population-based studies are needed to establish the safety of this drug. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Prabhat, Jain, Apoorva, Gautam, Ashish, Nigam, Ashwini Kumar, Pursnani, Nikhil, Farooqui, Maaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011523/
https://www.ncbi.nlm.nih.gov/pubmed/33816203
http://dx.doi.org/10.4103/picr.PICR_192_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011523/
https://www.ncbi.nlm.nih.gov/pubmed/33816203
http://dx.doi.org/10.4103/picr.PICR_192_18

Ejemplares similares